Amicus Therapeutics, Inc. (FOLD)
NASDAQ: FOLD · Real-Time Price · USD
9.80
+0.07 (0.72%)
Dec 20, 2024, 4:00 PM EST - Market closed

Amicus Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
2,9284,1613,4303,2186,0172,482
Upgrade
Market Cap Growth
-9.27%21.31%6.59%-46.51%142.44%36.86%
Upgrade
Enterprise Value
3,1234,3353,5273,1015,9482,173
Upgrade
Last Close Price
9.8014.1912.2111.5523.099.74
Upgrade
PS Ratio
6.0210.4210.4210.5323.0613.62
Upgrade
PB Ratio
16.3725.9827.8810.4721.015.21
Upgrade
P/TBV Ratio
---29.3767.928.91
Upgrade
EV/Sales Ratio
6.3310.8610.7110.1522.8011.92
Upgrade
Debt / Equity Ratio
2.492.783.671.431.540.44
Upgrade
Asset Turnover
0.640.530.400.340.300.22
Upgrade
Inventory Turnover
0.570.891.521.491.851.96
Upgrade
Quick Ratio
2.202.232.593.674.093.77
Upgrade
Current Ratio
3.152.883.054.094.474.04
Upgrade
Return on Equity (ROE)
-67.09%-107.04%-109.93%-84.37%-72.59%-86.99%
Upgrade
Return on Assets (ROA)
1.16%-6.12%-15.68%-13.95%-17.55%-22.92%
Upgrade
Return on Capital (ROIC)
1.49%-7.78%-19.32%-16.94%-21.55%-27.82%
Upgrade
Earnings Yield
-3.58%-3.64%-6.90%-7.78%-4.60%-14.36%
Upgrade
FCF Yield
-1.08%-1.84%-4.97%-6.41%-3.93%-10.90%
Upgrade
Buyback Yield / Dilution
-3.63%-2.11%-6.50%-4.85%-7.67%-29.40%
Upgrade
Total Shareholder Return
-3.63%-2.11%-6.50%-4.85%-7.67%-29.40%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.